Showing 261 - 280 results of 1,557 for search '"bowel"', query time: 0.06s Refine Results
  1. 261

    Transvaginal Management of Vaginal Cuff Dehiscence with Bowel Evisceration following Delayed Diagnosis by Samantha Bleull, Hunter Smith, Robert Shapiro

    Published 2017-01-01
    “…One of the most serious complications that can arise from hysterectomy is vaginal cuff dehiscence with subsequent bowel evisceration. Treatment via vaginal approach has been utilized in early cases of vaginal cuff dehiscence where the need for bowel resection is less likely. …”
    Get full text
    Article
  2. 262

    Defining Quality Indicators for Best-Practice Management of Inflammatory Bowel Disease in Canada by Geoffrey C Nguyen, Shane M Devlin, Waqqas Afif, Brian Bressler, Steven E Gruchy, Gilaad G Kaplan, Liliana Oliveira, Sophie Plamondon, Cynthia H Seow, Chadwick Williams, Karen Wong, Brian M Yan, Jennifer Jones

    Published 2014-01-01
    “…BACKGROUND: There is a paucity of published data regarding the quality of care of inflammatory bowel disease (IBD) in Canada. Clinical quality indicators are quantitative end points used to guide, monitor and improve the quality of patient care. …”
    Get full text
    Article
  3. 263

    In vitro Superoxide Production by Peripheral Neutrophils from Patients with Inflammatory Bowel Disease by O. H. Nielsen, D. Berild, I. Ahnfelt-Rønne

    Published 1994-01-01
    “…Activated polymorphonuclear leucocytes, which are accumulated in inflammatory lesions of inflammatory bowel disease, produce tissue destructive, oxygen derived free radicals and other inflammatory mediators. …”
    Get full text
    Article
  4. 264

    Pyogenic Granuloma: An Unusual Cause of Massive Gastrointestinal Bleeding from the Small Bowel by Dana C Moffatt, Paul Warwryko, Harminder Singh

    Published 2009-01-01
    “…Small bowel hemorrhage is responsible for approximately 4% of all cases of gastrointestinal bleeding. …”
    Get full text
    Article
  5. 265

    A Rare Case of Endometrial Cancer Metastatic to the Sigmoid Colon and Small Bowel by Jeffrey A. Hubers, Anurag Soni

    Published 2017-01-01
    “…Metastatic endometrial cancer to the small bowel or colon has been described but is quite rare. …”
    Get full text
    Article
  6. 266

    Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives by Arash Assadsangabi, Caroline A. Evans, Bernard M. Corfe, Alan Lobo

    Published 2019-01-01
    “…Inflammatory bowel disease (IBD) is a chronic relapsing/remitting inflammatory illness of the gastrointestinal tract of unknown aetiology. …”
    Get full text
    Article
  7. 267
  8. 268

    Therapeutic potential and mechanism of functional oligosaccharides in inflammatory bowel disease: a review by Xiaochun Yang, Deyong Zeng, Chongyang Li, Wenchen Yu, Guilin Xie, Yingchun Zhang, Weihong Lu

    Published 2023-11-01
    “…Inflammatory bowel disease (IBD) is characterized by recurrent attacks and long courses, and the number of patients has expanded rapidly year by year. …”
    Get full text
    Article
  9. 269
  10. 270

    Brown Bowel Syndrome in a Middle-Aged Woman with Chronic Idiopathic Malabsorption by Renato Parente, Maurizio Pinamonti, Stefania Martina

    Published 2019-01-01
    “…Brown bowel syndrome (BBS) is an extremely unusual condition characterized by an orange-brown discoloration of the bowel and intestinal motility disorders secondary to fat-soluble vitamin deficiency and malabsorption from many different causes. …”
    Get full text
    Article
  11. 271

    Herpes Simplex Proctitis Mimicking Inflammatory Bowel Disease in a Teenaged Male by Kristen E. Sandgren, Nathan B. Price, Warren P. Bishop, Patrick J. McCarthy

    Published 2017-01-01
    “…Though proctitis is most commonly due to inflammatory bowel disease (IBD), infectious etiologies must also be considered, including sexually transmitted causes of infectious proctitis. …”
    Get full text
    Article
  12. 272

    The Establishment of a National Tissue Bank for Inflammatory Bowel Disease Research in Canada by Stephen M Collins, Kevin McHugh, Ken Croitoru, Micheal Howorth

    Published 2003-01-01
    “…The Crohn’s and Colitis Foundation of Canada (CCFC) has established a national bank for tissue, serum and blood from patients with inflammatory bowel disease (IBD). Investigators from across the country submit material to the bank together with clinical data. …”
    Get full text
    Article
  13. 273

    Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment? by Christian Philipp Selinger, Konstantina Rosiou, Marco V Lenti

    Published 2024-06-01
    “…Inflammatory bowel disease (IBD) treatment was revolutionised with the arrival of biological therapy two decades ago. …”
    Get full text
    Article
  14. 274

    Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease by Guangxi Zhou, Lin Yu, Wenjing Yang, Wei Wu, Leilei Fang, Zhanju Liu

    Published 2016-01-01
    “…Background. Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronically remittent and progressive inflammatory disorders. …”
    Get full text
    Article
  15. 275

    Effect of Physician-Delivered Patient Education on the Quality of Bowel Preparation for Screening Colonoscopy by Tze-Yu Shieh, Ming-Jen Chen, Chen-Wang Chang, Chien-Yuan Hung, Kuang-Chun Hu, Yang-Che Kuo, Shou-Chuan Shih, Horng-Yuan Wang

    Published 2013-01-01
    “…Background. Inadequate bowel preparation is common in outpatients undergoing screening colonoscopy because of unawareness and poor adherence to instruction. …”
    Get full text
    Article
  16. 276

    Review of Rome-IV criteria for the irritable bowel syndrome: are there any basic changes? by A. A. Sheptulin, M. A. Vize-Khripunova

    Published 2018-08-01
    “…To analyze the changes in the Rome IV criteria of the irritable bowel syndrome (IBS) in comparison to their previous version. …”
    Get full text
    Article
  17. 277

    Therapy of Inflammatory Bowel Disease using New 5-ASA Compounds: An Introduction by Ulrich Klotz

    Published 1989-01-01
    “…However, the new azocompound olsalazine induced diarrhea or loose stool in at least 10 to 15% of the treated patients which might limit its use in inflammatory bowel disease (IBD). In conclusion, the ‘old’ metabolite 5-ASA, in a ‘new’ design, offers an effective and very safe choice for the treatment of IBD.…”
    Get full text
    Article
  18. 278

    The Impact of Farnesoid X Receptor Activation on Intestinal Permeability in Inflammatory Bowel Disease by Maja Stojancevic, Karmen Stankov, Momir Mikov

    Published 2012-01-01
    “…Defects in the intestinal epithelial barrier have been observed in several intestinal disorders such as inflammatory bowel disease (IBD). Recent studies have identified a number of factors that contribute to development of IBD including environmental triggers, genetic factors, immunoregulatory defects and microbial exposure. …”
    Get full text
    Article
  19. 279

    Inflammatory Bowel Disease with Cytoplasmic-Staining Antineutrophil Cytoplasmic Antibody and Extensive Colitis by Hugh James Freeman

    Published 1998-01-01
    “…A cohort of 18 patients with inflammatory bowel disease who were characterized by the presence of cytoplasmic-staining antineutrophil cytoplasmic antibody (cANCA) and extensive colitis is reported. …”
    Get full text
    Article
  20. 280